MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 71 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $133,373 | -30.9% | 27,844 | -1.2% | 0.02% | -29.4% |
| Q2 2023 | $193,115 | -12.1% | 28,192 | 0.0% | 0.03% | -12.8% |
| Q1 2023 | $219,616 | +2.4% | 28,192 | 0.0% | 0.04% | +5.4% |
| Q4 2022 | $214,541 | -6.7% | 28,192 | 0.0% | 0.04% | -14.0% |
| Q3 2022 | $230,000 | – | 28,192 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $11,469,458 | 5.52% |
| NEA Management Company, LLC | 7,692,298 | $59,923,001 | 4.14% |
| Cormorant Asset Management, LP | 2,893,717 | $22,542 | 1.48% |
| Alphabet Inc. | 1,464,015 | $11,404,677 | 0.63% |
| Avoro Capital Advisors LLC | 4,325,000 | $33,691,750 | 0.50% |
| Casdin Capital, LLC | 510,882 | $3,979,771 | 0.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $242,705 | 0.10% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $219,616 | 0.04% |
| UBS OCONNOR LLC | 95,528 | $744,163 | 0.02% |
| ExodusPoint Capital Management, LP | 261,593 | $2,038 | 0.02% |